Sin-Hua Moi

Jun 4, 2024 | mdpi.com | William Winardi |Sin-Hua Moi |Yu-wen Cheng |Thomas Winardi

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

Mar 14, 2024 | nature.com | Sin-Hua Moi

AbstractThe present study aimed to elucidate the prognostic mutation signature (PMS) associated with long-term survival in a diffuse large B-cell lymphoma (DLBCL) cohort. All data including derivation and validation cohorts were retrospectively retrieved from The Cancer Genome Atlas (TCGA) database and whole-exome sequencing (WES) data.

Dec 11, 2023 | journals.plos.org | Sin-Hua Moi |Yu-Jiun Chan |Tzuo-Yun Lan |Heng-Jui Chang

Loading metrics Open Access Peer-reviewedResearch Article Citation: Chang H-J, Moi S-H, Chan Y-J, Lan T-Y (2023) A non-socially-sensitive predictive model of prostate cancer for Asian males with benign prostatic hyperplasia: A multi-site cross-sectional case-control study. PLoS ONE 18(12): e0295608.

Aug 23, 2023 | mdpi.com | Sin-Hua Moi |Cheng-Hong Yang |Li-Yeh Chuang |Pai-Wei Su

1. IntroductionAcinetobacter baumannii, a gram-negative opportunistic pathogen, thrives within hospital settings, enduring adverse circumstances like dehydration, lack of nutrients, and antimicrobial interventions [1,2]. In the realm of antimicrobial investigation, the identification of numerous antibiotics was sequentially succeeded by the rise of antibiotic resistance. Presently, the escalation of bacterial antibiotic resistance persists.

Apr 24, 2023 | mdpi.com | Tai-Hsin Tsai |Cheng-Yu Tsai |Sin-Hua Moi |Chieh-Hsin Wu

Abstract:2-Cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid-9,11-dihydro-trifluoroethyl amide (CDDO-dhTFEA) has antioxidant and anti-inflammatory activities; however, whether CDDO-dhTFEA has anticancer effects is unclear. The objective of this research was to investigate the possibility of CDDO-dhTFEA as a potential cancer-fighting treatment in glioblastoma cells.